All Stories

  1. Pitfalls of Early Systemic Corticosteroids Home Therapy in Older Patients with COVID-19 Pneumonia
  2. A Randomized, Open-Label Study to Assess Efficacy of Weekly Assumption of Cholecalciferol versus Calcifediol in Older Patients with Hypovitaminosis D
  3. A Randomized, Open-Label Study to Assess Efficacy of Weekly Assumption of Cholecalciferol Versus Calcifediol in Older Patients With Hypovitaminosis D
  4. Different glomerular filtration rate estimating formula for prescribing DOACs in oldest patients: appropriate dosage and bleeding risk. Post hoc analysis of a prospective cohort
  5. Behavioral and Psychological Symptoms in Dementia (BPSD) and the Use of Antipsychotics
  6. Real-World Performance of the American Thyroid Association Risk Estimates in Predicting 1-Year Differentiated Thyroid Cancer Outcomes: A Prospective Multicenter Study of 2000 Patients
  7. Spontaneous muscle hematoma in older patients with COVID-19: two case reports and literature review
  8. Comprehensive geriatric assessment in older adults with cancer: Recommendations by the Italian Society of Geriatrics and Gerontology (SIGG)
  9. Pneumonia Lung Ultrasound Score ( PLUS ): A New Tool for Detecting Pneumonia in the Oldest Patients
  10. High glucose and COVID-19 outcomes
  11. Thyroid hormones ratio is a major prognostic marker in advanced metastatic colorectal cancer: Results from the phase III randomised CORRECT trial
  12. Plasma redox and inflammatory patterns during major depressive episodes: a cross-sectional investigation in elderly patients with mood disorders
  13. Uric acid and late-onset Alzheimer’s disease: results from the ReGAl 2.0 project
  14. Understanding Factors Associated With Psychomotor Subtypes of Delirium in Older Inpatients With Dementia
  15. The Use of Antipsychotic Drugs for Treating Behavioral Symptoms in Alzheimer’s Disease
  16. 30-Day Potentially Preventable Hospital Readmissions In Older Patients: Clinical Phenotype And Health Care Related Risk Factors
  17. Effectiveness of Multi-Prognostic Index in older patients with advanced malignancies treated with immunotherapy
  18. Editorial: Endocrine Frailty in the Elderly
  19. Why are so few antipsychotic drugs licensed for Alzheimer’s disease related behavioral and psychological symptoms?
  20. Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE)
  21. Overt and Subclinical Hypothyroidism in the Elderly: When to Treat?
  22. Drug Prescription and Delirium in Older Inpatients
  23. Hypothyroidism in the Elderly: Who Should Be Treated and How?
  24. Prognostic Value of Thyroid Hormone Ratios in Patients With Advanced Metastatic Colorectal Cancer Treated With Regorafenib: The TOREADOR Study
  25. Degree of Peripheral Thyroxin Deiodination, Frailty, and Long-Term Survival in Hospitalized Older Patients
  26. Are Evidence-Based Guidelines Reflected in Clinical Practice? An Analysis of Prospectively Collected Data of the Italian Thyroid Cancer Observatory
  27. Thyroid Disrupting Chemicals
  28. Thyroid Disrupting Chemicals
  30. MicroRNA-based molecular classification of papillary thyroid carcinoma
  31. Clinical differences among the elderly admitted to the emergency department for accidental or unexplained falls and syncope
  32. P2X7 Receptor and APOE Polymorphisms and Survival from Heart Failure: A Prospective Study in Frail Patients in a Geriatric Unit
  33. Stereotactic Body Radiotherapy in Patients with Lung Oligometastases from Colorectal Cancer
  34. Expected and actual adverse drug-drug interactions in elderly patients accessing the emergency department: data from the ANCESTRAL-ED study
  35. Cognitive Function and the Ageing Process: The Peculiar Role of Mild Thyroid Failure
  36. Editorial (Thematic Issue: Endocrine Disorders and Cognitive Function in the Elderly)
  37. The difference in activity of daily living (ADL) and mortality in patients aged over 80 years with femoral neck fracture treated with hemiarthroplasty or osteosynthesis at 2 years of follow-up
  38. “Delirium Day”: a nationwide point prevalence study of delirium in older hospitalized patients using an easy standardized diagnostic tool
  39. Major adverse cardiovascular and cerebral events in hypothyroid patients undergoing percutaneous coronary intervention
  40. [18F]Choline PET/CT and stereotactic body radiotherapy on treatment decision making of oligometastatic prostate cancer patients: preliminary results
  41. Papillary thyroid carcinomas with biochemical incomplete or indeterminate responses to initial treatment: repeat stimulated thyroglobulin assay to identify disease-free patients
  42. The Emerging Role of Sunitinib in the Treatment of Advanced Epithelial Thyroid Cancer
  43. Subclinical Hypothyroidism and Cognitive Impairment: Systematic Review and Meta-Analysis
  44. Potential drug–drug interactions in Alzheimer patients with behavioral symptoms
  45. Cardiovascular Risk and Quality of Life in Elderly People with Mild Thyroid Hormone Deficiency
  46. Cholinesterase inhibitors for Parkinson's disease: a systematic review and meta-analysis
  47. Cognitive Function and Quality of Life in Mild Thyroid Hormone Deficiency
  48. Clinical Aggressiveness and Long-Term Outcome in Patients with Papillary Thyroid Cancer and Circulating Anti-Thyroglobulin Autoantibodies
  49. Vestibular disorders in euthyroid patients with Hashimoto's thyroiditis: role of thyroid autoimmunity
  50. Prevalence of Thyroid Cancer in Multinodular Goiter Versus Single Nodule: Iodine Intake and Cancer Phenotypes
  51. Reply on the Letter by Stott et al. ‘The Dilemma of Treating Subclinical Hypothyroidism: Risk that Current Guidelines Do More Harm than Good'
  52. Is Subclinical Hypothyroidism a Cardiovascular Risk Factor in the Elderly?
  53. Subclinical Hypothyroidism and Heart Failure Risk in Older People
  54. Papillary Thyroid Cancer: Time Course of Recurrences During Postsurgery Surveillance
  55. 2013 ETA Guideline: Management of Subclinical Hypothyroidism
  56. Acute portal vein thrombosis precipitated by indomethacin in a HCV-positive elderly patient
  57. Age and Gender Substantially Influence the Relationship Between Thyroid Status and the Lipoprotein Profile: Results from a Large Cross-Sectional Study
  58. Soluble Human Leukocyte Antigen-G and Its Insertion/Deletion Polymorphism in Papillary Thyroid Carcinoma: Novel Potential Biomarkers of Disease?
  59. Age and Gender Substantially Influence the Relationship Between Thyroid Status and the Lipoprotein Profile: Results from a Large Cross-Sectional Study
  60. Long-Term Surveillance of Papillary Thyroid Cancer Patients Who Do Not Undergo Postoperative Radioiodine Remnant Ablation: Is There a Role for Serum Thyroglobulin Measurement?
  61. Mild Thyroid Deficiency in the Elderly
  62. Folate, Homocysteine, Vitamin B12, and Polymorphisms of Genes Participating in One-Carbon Metabolism in Late-Onset Alzheimer's Disease Patients and Healthy Controls
  63. Adipocytokines mark insulin sensitivity in euthyroid Hashimoto’s patients
  64. Synergistic phage-antibiotic combinations for the control of Escherichia coli biofilms in vitro
  65. DNMT3B Promoter Polymorphisms and Risk of Late Onset Alzheimer’s Disease
  66. Off-Label Use of Sunitinib in Patients with Advanced, Epithelial Thyroid Cancer: A Retrospective Analysis
  67. Clarithromycin-induced rhabdomyolysis: a case report
  68. Symptoms in Euthyroid Hashimoto's Thyroiditis: Is There a Role for Autoimmunity Itself?
  69. The Effect ofGinkgo bilobaExtract on Genotoxic Damage in Patients with Differentiated Thyroid Carcinoma Receiving Thyroid Remnant Ablation with Iodine-131
  70. Incidence and Prevalence of Hypothyroidism in Patients Affected by Chronic Heart Failure: Role of Amiodarone
  71. Symptoms in Euthyroid Hashimoto’s Thyroiditis: Is There a Role for Autoimmunity Itself?
  72. Is Elastography Actually Useful in the Presurgical Selection of Thyroid Nodules with Indeterminate Cytology?
  73. The Emerging Role of Sunitinib in the Treatment of Advanced Epithelial Thyroid Cancer: Our Experience and Review of Literature
  74. Fasting hyperglycaemia and in-hospital mortality in elderly population
  75. Thyroid autoimmunity may represent a predisposition for the development of fibromyalgia?
  76. Identification and Optimal Postsurgical Follow-Up of Patients with Very Low-Risk Papillary Thyroid Microcarcinomas
  77. Hypothyroidism and Intermediate Metabolism: A Complex Relationship
  78. The AGILE silicon tracker: Pre-launch and in-flight configuration
  79. Insulinoma presenting as idiopathic hypersomnia
  80. Elevated Antithyroid Peroxidase and Antinuclear Autoantibody Titers in Ménière’s Disease Patients: More than a Chance Association?
  81. Recurrence of Graves' Disease in Thyroglossal Duct Remnants: Relapse After Total Thyroidectomy
  82. Non-thyroidal illness syndrome and short-term survival in a hospitalised older population
  83. Chromosome Translocation Frequency after Radioiodine Thyroid Remnant Ablation: A Comparison between Recombinant Human Thyrotropin Stimulation and Prolonged Levothyroxine Withdrawal
  84. Surgical aspects of thyroid nodules previously treated by ethanol injection
  85. Treatment of hyperfunctioning thyroid nodules with percutaneous ethanol injection: Eight years' experience
  86. New Echocardiographic Techniques in the Evaluation of Left Ventricular Mechanics in Subclinical Thyroid Dysfunction
  87. Effect of Type I Interferon(s) on Cell Viability and Apoptosis in Primary Human Thyrocyte Cultures
  88. Inducible Nitric Oxide Synthase Is Involved in Endothelial Dysfunction of Mesenteric Small Arteries from Hypothyroid Rats
  89. 1513A>C Polymorphism in the P2X7Receptor Gene in Patients with Papillary Thyroid Cancer: Correlation with Histological Variants and Clinical Parameters
  90. The AGILE Mission
  91. Hypothyroidism and Endothelial Function: A Marker of Early Atherosclerosis?
  92. Possible association between thyroid autoimmunity and Menière's disease
  93. Increased P2X7Receptor Expression and Function in Thyroid Papillary Cancer: A New Potential Marker of the Disease?
  94. Anticlastogenic Effect of Ginkgo Biloba Extract in Graves’ Disease Patients Receiving Radioiodine Therapy
  95. Design of a CZT gamma-camera for GRB and fast transient follow-up: a wide-field-monitor for the EDGE mission
  96. Recombinant human TSH acutely impairs endothelium-dependent vasodilation
  97. Early abnormalities of left ventricular myocardial characteristics associated with subclinical hyperthyroidism
  98. Thyroid Function and Carotid Artery Intima - Media Thickness
  99. Low-Grade Systemic Inflammation Causes Endothelial Dysfunction in Patients with Hashimoto’s Thyroiditis
  100. Erratum
  101. Recombinant Human Thyrotropin Reduces Endothelium-Dependent Vasodilation in Patients Monitored for Differentiated Thyroid Carcinoma
  102. Early textural and functional alterations of left ventricular myocardium in mild hypothyroidism
  103. A study of the possibility of curing Graves?? disease based on the desired reduction of thyroid mass (volume) as a consequence of 131I therapy: a speculative paper
  104. Evaluation of Endothelial Function in Subclinical Thyroid Dysfunction
  105. Does Treating Subclinical Hypothyroidism Improve Markers of Cardiovascular Risk?
  106. Active and passive shielding design optimization and technical solutions for deep sensitivity hard x-ray focusing telescopes
  107. Extracellular Adenosine 5′-Triphosphate Modulates Interleukin-6 Production by Human Thyrocytes through Functional Purinergic P2 Receptors
  108. Muscle Metabolism and Exercise Tolerance in Subclinical Hypothyroidism: A Controlled Trial of Levothyroxine
  109. Long-Term Follow-Up of 106 Multiple Sclerosis Patients Undergoing Interferon-β 1a or 1b Therapy: Predictive Factors of Thyroid Disease Development and Duration
  110. A predictive mathematical model for the calculation of the final mass of Graves' disease thyroids treated with 131 I
  111. Subclinical Thyroid Disease and Cardiovascular Disease
  112. Type I Interferons Modulate the Expression of Thyroid Peroxidase, Sodium/Iodide Symporter, and Thyroglobulin Genes in Primary Human Thyrocyte Cultures
  114. Effect of Levothyroxine Replacement on Lipid Profile and Intima-Media Thickness in Subclinical Hypothyroidism: A Double-Blind, Placebo- Controlled Study
  115. Thyroid autoimmunity and dysfunction associated with type I interferon therapy
  116. Oxidative and genotoxic damage after radio‐iodine therapy of Graves' hyperthyroidism
  117. Laparoscopic treatment of pancreatic insulinoma
  118. Impaired Endothelium-Dependent Vasodilatation in Subclinical Hypothyroidism: Beneficial Effect of Levothyroxine Therapy
  119. Prevalence of Cancer in Follicular Thyroid Nodules: Is There Still a Role for Intraoperative Frozen Section Analysis?
  120. Discordant Effect of IFN- β 1a Therapy on Anti-IFN Antibodies and Thyroid Disease Development in Patients with Multiple Sclerosis
  121. Lipoprotein Profile in Subclinical Hypothyroidism: Response to Levothyroxine Replacement, a Randomized Placebo-Controlled Study
  122. Lipoprotein Profile in Subclinical Hypothyroidism: Response to Levothyroxine Replacement, a Randomized Placebo-Controlled Study
  123. Effect of Levothyroxine on Cardiac Function and Structure in Subclinical Hypothyroidism: A Double Blind, Placebo-Controlled Study
  124. Effect of Levothyroxine on Cardiac Function and Structure in Subclinical Hypothyroidism: A Double Blind, Placebo-Controlled Study
  125. Surgical and Pathological Changes After Percutaneous Ethanol Injection Therapy of Thyroid Nodules
  126. Ultrasonic myocardial textural analysis in subclinical hypothyroidism
  127. Long-term interferon  -1b therapy for MS: Is routine thyroid assessment always useful?
  128. Insulin: new roles for an ancient hormone
  129. Effect of 1-year treatment with interferon-beta1b on thyroid function and autoimmunity in patients with multiple sclerosis
  130. Neuromuscular symptoms and dysfunction in subclinical hypothyroid patients: beneficial effect of L-T4 replacement therapy
  131. Thyroid function and autoimmunity in Parkinson's disease: a study of 101 patients
  132. Is Percutaneous Ethanol Injection a Useful Alternative for the Treatment of the Cold Benign Thyroid Nodule? Five Years' Experience
  133. Clinical and Biochemical Features of Muscle Dysfunction in Subclinical Hypothyroidism
  134. Clinical and Biochemical Features of Muscle Dysfunction in Subclinical Hypothyroidism
  135. Appearance of Graves’ disease after percutaneous ethanol injection for the treatment of hyperfunctioning thyroid adenoma
  136. Five-year follow-up of percutaneous ethanol injection for the treatment of hyperfunctioning thyroid nodules: a study of 117 patients
  137. Treatment of solitary autonomous thyroid nodules by percutaneous ethanol injection: results of an Italian multicenter study. The Multicenter Study Group
  138. Age-Related Modifications in the Regulation of the Hypothalamic-Pituitary-Thyroid Axis
  139. Percutaneous ethanol injection for thyroid cysts: a word of caution
  140. Overview of the SAX x-ray instruments development
  141. Prolonged treatment of hirsutism with flutamide alone in patients affected by polycystic ovary syndrome
  142. Cold thyroid nodules: A new application of percutaneous ethanol injection treatment
  143. Percutaneous aspiration and ethanol sclerotherapy for thyroid cysts
  144. Performances of the pulse shape electronics of the high energy experiment PDS on board the X-ray astronomy satellite SAX
  145. Seveso Oak Forest: The gradual reconstruction of an area contaminated by TCDD
  146. Letters to the Editors
  147. Coagulation and fibrinolytic system impairment in insulin dependent diabetes mellitus
  148. Percutaneous ethanol injection treatment of autonomously functioning single thyroid nodules: Optimization of treatment and short term outcome
  149. Percutaneous ethanol injection treatment of autonomous thyroid adenoma: hormonal and clinical evaluation
  150. Occupational thyroid disease
  151. Autonomous thyroid nodule and percutaneous ethanol injection
  152. Long-Term Intramuscular Administration of Thyrotropin-Releasing Hormone Tartrate in Patients with Cerebrovascular Disease: Effects on the Pituitary-Thyroid Axis
  153. Effect of fenfluramine on prolactin and thyroid-stimulating-hormone response to thyrotropin-releasing-hormone in obese and normal women
  155. TSH-displacing activity versus TSH-binding inhibiting activity of immunoglobulins from patients with Graves’ disease
  156. Thyroid-Stimulating Immunoglobulins
  158. Interference of thyroglobulin in TSAb detection by radio-receptor assay
  159. Use of solubilized radioiodinated thyroid plasma membranes for purification of TSH-receptor by affinity chromatography